Missed a GLP-1 Dose From a Shipping Delay? Label Rules for Restarting

If your refill showed up late and you are past your injection day, the answer depends on which drug you take and how many days have passed. Each FDA label sets its own missed-dose window: 2 days before the next dose for Wegovy injection, 4 days after the missed dose for Zepbound and Mounjaro, 5 days for Ozempic. Once the gap grows to two or more missed weekly doses, the Wegovy label says to restart at a lower dose rather than jump back in, and that decision belongs to your prescriber, not the shipping tracker.

First, find your window

A late package does not change the label rules. The clock runs from your scheduled dose day, not from the day the box arrives. Before you open the pen, check the date of your last dose (your injection log, phone reminder, or the platform's dose tracker) and compare it with the rule for your product.

Sources: Wegovy injection PI (rev. 06/2026); Ozempic PI (rev. 05/2026); Zepbound PI (rev. 8/2026); Mounjaro PI (rev. 8/2026); Wegovy tablets PI (rev. 06/2026); Foundayo PI (rev. 7/2026); Saxenda PI (rev. 02/2026).

Notice how the Wegovy injection rule is framed. It counts backward from your next dose, while the Ozempic, Zepbound and Mounjaro rules count forward from the missed one. Same idea, different arithmetic, which is an easy place to get mixed up when you are reading a label at the kitchen table.

Why a longer gap can mean starting lower

Two of the labels that address longer gaps state the reason. Saxenda's label says restarting at 0.6 mg is meant "to reduce the risk of gastrointestinal adverse reactions associated with reinitiation of treatment." The Foundayo label likewise says its restart-lower instruction is meant "to reduce the risk of gastrointestinal adverse reactions."

The practical logic: dose escalation exists so your body adjusts to nausea, vomiting and diarrhea gradually. After enough time off the drug, you may lose some of that tolerance. The Zepbound label warns that GI reactions are "sometimes severe" and that kidney injury has been reported mostly in patients whose vomiting or diarrhea led to dehydration. Jumping straight back to a high maintenance dose after a long gap is the scenario those restart rules are trying to prevent.

Where a label is silent on longer gaps (Zepbound, Mounjaro, Ozempic, and the Wegovy tablet dosing section), that silence is not permission to resume at full dose. It means the label leaves the call to the prescriber. Some prescribers resume the same dose after a short gap and step down after a longer one; the right answer depends on your dose, how long you have been on it, and how you tolerated it.

The two-minute decision checklist

1. Write down your last dose date and strength. Not the date you ordered or the date the box shipped.
2. Count the days since the missed dose (or until the next one, for Wegovy injection).
3. Match it to your label's window in the table above.
4. If you are inside the window and feel normal, the label allows the missed dose. Many people still send a quick note to the prescriber so the chart is accurate.
5. If you are outside the window, skip the missed dose and resume on your usual day, per the label, unless you have missed enough doses to hit a restart-lower rule.
6. If you have missed two or more weekly doses, or seven or more daily Foundayo doses, message your prescriber before injecting or taking anything. Ask whether you should restart at a lower dose.
7. Check the product itself. If the shipment sat in heat or cold, confirm the storage instructions in the patient leaflet before you use it, and report any problem to the pharmacy.

What to send an async prescriber

Most telehealth GLP-1 programs route dose questions through a message thread that a clinician reads later. A vague message ("my order was late, what do I do?") often gets a reply asking for the same details you could have sent the first time. A complete message lets the clinician answer in one pass.

Here is a template you can copy and fill in:

1. Drug and form: "Zepbound single-dose vial" or "Wegovy pen" or "Foundayo tablets."
2. Current dose: the strength you were on when the gap started.
3. Last dose date: the actual date you last injected or took a tablet.
4. Doses missed: how many scheduled doses passed, and why (shipping delay, pharmacy backorder).
5. When the new supply arrived and whether it looked intact (sealed, not frozen, not hot to the touch).
6. Symptoms: any nausea, vomiting, diarrhea, abdominal pain, or reduced fluid intake right now.
7. Other changes: new medicines, a planned procedure, or for anyone with diabetes, recent glucose readings.
8. Your question: "Should I resume at my current dose, step down, or wait until my next scheduled day?"

Then wait for the answer before taking the dose if you are outside the label window. If the platform's stated response time is longer than your window, say so in the message and ask whether a clinician can respond sooner.

Hypothetical scenarios (illustrative only)

Scenario A. Someone on Zepbound injects on Sundays. The refill arrives Tuesday. That is 2 days after the missed dose, inside the 4-day window, so the label allows the dose now. They would then return to their regular schedule; a note to the prescriber keeps the record straight.

Scenario B. Someone on Wegovy injection injects on Mondays. A carrier delay means the pen arrives on Saturday of the following week, after two Mondays have passed with no dose. That is two consecutive missed doses, which matches the label's restart-lower rule. The right move is to message the prescriber and ask what dose to restart at, not to inject the maintenance dose that arrived.

Scenario C. Someone on Foundayo runs out of tablets and goes four days without a dose. The label's restart-lower rule starts at 7 consecutive missed doses, so four days falls short of it. The label says to take the dose as soon as possible without doubling up. It is still worth telling the prescriber, especially if GI symptoms return.

Questions to put to your platform after a delay

A missed dose caused by shipping is a logistics failure, and it is fair to ask how the platform will keep it from repeating. Useful questions:

• How early can I reorder? Is there a refill buffer, and does it change if a shipment is delayed?
• Will you reship a replacement if the carrier loses a package or it arrives damaged? Who pays?
• Can my prescription be sent to a local pharmacy for a one-time fill while a shipment is stuck?
• Will a clinician adjust my dose plan in writing if I need to restart lower, and does that change my next order?
• Does a restart-lower plan mean a different pen strength must ship, and how fast?

Get answers in writing in the portal. If you need a lower strength to restart, make sure the next order matches the new plan, so you are not left holding only the higher strength.

What a missed dose does not mean

It does not automatically mean you must start over from the lowest dose. The labels that set restart rules say "reinitiate dosage escalation at a lower dosage," which leaves the specific step to the prescriber. It also does not mean you have "lost" your progress; it means the next few weeks may need a slower ramp.

It also does not mean the platform's auto-ship schedule is right. If your dose plan changes, your shipments may need to change with it. Confirm both.

A note on compounded and non-label products

Every rule in this article comes from FDA-approved prescribing information. Compounded semaglutide or tirzepatide is not covered by those labels, and its concentration and dosing units can differ from branded pens. If you use a compounded product, ask your prescriber which missed-dose rule they want you to follow, and get it in writing.

Where this guide stops

This article summarizes label language as of October 2026; it does not tell you what dose to take. Contact your prescriber or seek urgent care if you have severe or persistent abdominal pain (with or without vomiting), signs of dehydration such as very little urine or dizziness, or, if you have diabetes, low blood sugar symptoms. Those situations need a clinician who can assess you, not a missed-dose table.

If you take insulin or a sulfonylurea along with a GLP-1, a restart is also a glucose question. Coordinate with whoever manages your diabetes before resuming.

Sources

1. Wegovy (semaglutide) injection prescribing information, Novo Nordisk (rev. 06/2026)
2. Ozempic (semaglutide) injection prescribing information, Novo Nordisk (rev. 05/2026)
3. Zepbound (tirzepatide) prescribing information, Eli Lilly (rev. 8/2026)
4. Mounjaro (tirzepatide) prescribing information, Eli Lilly (rev. 8/2026)
5. Wegovy (semaglutide) tablets prescribing information, FDA (rev. 06/2026)
6. Foundayo (orforglipron) prescribing information, Eli Lilly (rev. 7/2026)
7. Saxenda (liraglutide) injection prescribing information, Novo Nordisk (rev. 02/2026)

Medical disclaimer: This article is general information, not medical advice, and does not replace a licensed clinician who knows your history. Approvals, labels, coverage and prices change; check the linked sources and talk with your prescriber or pharmacist before making decisions about any medication.